Information Provided By:
Fly News Breaks for May 18, 2015
NVS
May 18, 2015 | 07:38 EDT
After speaking with two Novartis executives, Bernstein says that the company has more Phase 3 drug activity than the firm has previously anticipated. As a result, the firm thinks the company's 2015-2016 performance could beat expectations. It identifies Novartis as one of its top three picks and keeps an Outperform rating onthe shares.
News For NVS From the Last 2 Days
There are no results for your query NVS